Exploring immune checkpoints as potential therapeutic targets in atherosclerosis. [electronic resource]
- Cardiovascular research 03 2018
- 368-377 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1755-3245
10.1093/cvr/cvx248 doi
Animals Anti-Inflammatory Agents--therapeutic use Arteries--drug effects Atherosclerosis--drug therapy Drug Design Humans Immunologic Factors--therapeutic use Inflammation Mediators--antagonists & inhibitors Molecular Targeted Therapy Plaque, Atherosclerotic Signal Transduction--drug effects